3 months ago
LLY
AnalystsTim AndersonTim Anderson's Stock Forecasts
AnalystsTim Anderson
Sectors:
Industries:
Analyst Ranking
Top 22%
#1165 out of 5221 analysts
Average Return
+10.74%
Win Rate
52%14 out of 27
Risk vs Reward
Poor
Good
Tim Anderson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Metsera IncMTSR | +157.96% | $27.33 | $70.50 | 2025-02-24 - 2025-11-14 | Strong Buy |
Metsera IncMTSR | +101.20% | $35.04 | $70.50 | 2025-08-27 - 2025-11-14 | Strong Buy |
Apogee Therapeutics IncAPGE | +87.06% | $36.62 | $68.50 | 2025-08-27 - 2026-03-19 | Strong Buy |
Gilead Sciences IncGILD | +43.27% | $105.96 | $151.81 | 2025-02-12 - 2026-02-12 | Strong Buy |
Moderna IncMRNA | +31.97% | $41.51 | $28.24 | 2024-12-09 - 2025-12-09 | Sell |
Tim Anderson Analyst Color
Get additional color on Tim Anderson's coverage of popular stocks
3 months ago
MRK
3 months ago
BMY
6 months ago
PFE
8 months ago
JNJ
a year ago
JNJ
a year ago
GILD
a year ago
MRK
a year ago
JNJ
a year ago
JNJ
a year ago
PFE
a year ago
LLY
Tim Anderson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Johnson & JohnsonJNJ | 10 | Hold | $221.00 | -6.99% | Maintains | 2 months ago |
Eli Lilly & CoLLY | 2 | Strong Buy | $1,268.00 | +38.20% | Maintains | 3 months ago |
Merck & Co IncMRK | 5 | Strong Buy | $120.00 | +5.08% | Maintains | 3 months ago |
Bristol Myers Squibb CoBMY | 2 | Strong Buy | $61.00 | +4.97% | Upgrades | 3 months ago |
Regeneron Pharmaceuticals IncREGN | 3 | Sell | $627.00 | -14.98% | Maintains | 5 months ago |
Pfizer IncPFE | 3 | Hold | $30.00 | +9.45% | Maintains | 6 months ago |
Amgen IncAMGN | 5 | Sell | $272.00 | -22.27% | Maintains | 6 months ago |
Apogee Therapeutics IncAPGE | 1 | Strong Buy | $87.00 | +27.01% | Maintains | 7 months ago |
Metsera IncMTSR | 2 | Strong Buy | $50.00 | -29.08% | Maintains | 7 months ago |
Aardvark Therapeutics IncAARD | 3 | Strong Buy | $25.00 | +410.20% | Maintains | 7 months ago |
Abbvie IncABBV | 6 | Hold | $204.00 | -1.08% | Maintains | a year ago |
Gilead Sciences IncGILD | 3 | Strong Buy | $126.00 | N/A | Maintains | a year ago |
Moderna IncMRNA | 2 | Sell | $34.00 | N/A | Maintains | a year ago |
Biogen IncBIIB | 1 | Hold | $178.00 | N/A | Reinstates | a year ago |
Novartis AgNVS | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.